Results for tag: "Dysphagia Management"

Dysphagia Management is a sub-sector of Gastrointestinal Drugs that focuses on the diagnosis and treatment of swallowing disorders. Dysphagia is a condition that affects the ability to swallow food and liquids, and can be caused by a variety of medical conditions. Dysphagia Management involves the use of medications, diet modifications, and other therapies to improve swallowing function. Treatment options may include medications to reduce muscle spasms, diet modifications to reduce the risk of aspiration, and physical therapy to improve swallowing coordination. The Dysphagia Management market is comprised of pharmaceutical companies, medical device manufacturers, and healthcare providers. Companies in the market include AbbVie, AstraZeneca, GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. Show Less Read more